Clinical Trial Update: A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435 [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the relative bioavailability of tablet formulations of GSK2248761 in healthy adult subjects and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GSK2248761 (GSK2248761)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infections, Human Immunodeficiency Virus and Herpesviridae, Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED